Close
Nordic 9Nordic 9

NextImmune (private company)

Switzerland nextimmune.com
See something wrong or missing? Let us know
Offices:Basel
Industry:BiotechHealth servicesPharma
Business model:B2B

NextImmune is a biotechnology company from Switzerland that ocuses on the research and development of a new generation of immunosuppressive drugs for autoimmune diseases and Organ Transplantation

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 154.5k

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to NextImmune

Name Criteria
Ireland Relevium
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
France AbolerIS Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Athera
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden AttgeNO
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Finland Causalus
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden Cinclus Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Oui
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Finland DelSiTech
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Gradientech
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden iCellate
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Top